Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral antibiotic absorption in adults with short bowel syndrome
NL-OMON27546Not yet recruiting
- Sponsor
- Radboudumc
- Start
- Nov 2019
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of clindamycin, ciprofloxacin, flucloxacillin and fluconazole in short bowel syndrome (SBS) (2 arms), sponsored by Radboudumc. Primary endpoint: Enteral absorption of orally administered study drugs. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
clindamycinciprofloxacinflucloxacillinfluconazole
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NL-OMON27546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27546.